Abstract
Hypoxic pulmonary vasoconstriction (HPV) occurs during both fetal and postnatal development and plays a critical role in matching regional alveolar perfusion with ventilation in humans and animals. HPV also contributes significantly to the development of pulmonary hypertension. Although the molecular mechanisms of HPV and pulmonary hypertension remain incompletely understood, increasing evidence demonstrates that hypoxia induces an elevated intracellular reactive oxygen species concentration ([ROS]i) in pulmonary artery smooth muscle cells (PASMCs). The increased [ROS]i is attributed to the mitochondrial electron transport chain (ETC) and plasmalemmal NADPH oxidase (NOX); however, the mitochondrial ETC is a primary source for the elevated [ROS]i. Our studies reveal that mitochondrial ROS can specifically increase the activity of protein kinase C-ε, activate NOX, and then induce more ROS production (i.e., ROS-induced ROS production, RIRP). Mitochondrial ROS production is principally mediated by Rieske iron–sulfur protein (RISP) at the complex III. The increased [ROS]i causes an elevation of intracellular Ca2+ concentration ([Ca2+]i), thereby leading to HPV and associated pulmonary hypertension. Ryanodine receptor-2 (RyR2)/Ca2+ release channel on the sarcoplasmic reticulum (SR) serves as a most valuable player in the elevated [Ca2+]i. Our recent data indicate that RyR2-induced Ca2+ release can enhance RISP-mediated increase in mitochondrial ROS concentration ([ROS]mito), and that the mitochondrial Ca2+ uniporter is involved in elevating [ROS]mito. Based on the existing reports and our unpublished data, we conclude that the cross talk between [ROS]mito and [Ca2+]i, that is RISP-dependent mitochondrial ROS-induced RyR2-mediated SR Ca2+ release (ROS-induced Ca2+ release, RICR) and RyR2-mediated SR Ca2+ release-induced RISP-dependent mitochondrial ROS production (Ca2+-induced ROS production, CIRP), may form a positive reciprocal loop in mediating HPV and also possibly pulmonary hypertension.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- [Ca2+]i :
-
Intracellular Ca2+ concentration
- [Ca2+]mito :
-
Intramitochondrial Ca2+ concentration
- [ROS]i :
-
Intracellular ROS concentration
- [ROS]mito :
-
Intramitochondrial ROS concentration
- BSO:
-
Buthionine sulfoximine
- CIRP:
-
Ca2+-induced ROS production
- COPD:
-
Chronic obstructive pulmonary disease
- DAG:
-
Diacylglycerol
- ER/SR:
-
Endoplasmic reticulum/sarcoplasmic reticulum
- ETC:
-
Electron transport chain
- HPV:
-
Hypoxic pulmonary vasoconstriction
- IP3 :
-
Inositol 1,4,5-trisphosphate
- IP3R:
-
Inositol 1,4,5-trisphosphate receptor
- MCU:
-
Mitochondrial Ca2+ uniporter
- MEFs:
-
Mouse embryonic fibroblasts
- NOX:
-
NADPH oxidase
- PASMCs:
-
Pulmonary arterial smooth muscle cells
- PKC:
-
Protein kinase C
- RICR:
-
ROS-induced Ca2+ release
- RIPR:
-
ROS-induced ROS production
- RISP:
-
Rieske iron–sulfur protein
- ROCK:
-
Rho kinase
- ROS:
-
Reactive oxygen species
- RyR2:
-
Ryanodine receptor 2
- SOCC:
-
Store operated Ca2+ channel
- SOD:
-
Superoxide dismutase
- STIM:
-
Stromal interaction molecule
- TRPC:
-
Canonical transient receptor potential
- TRPV:
-
Vanilloid transient receptor potential
References
Rathore, R., Zheng, Y. M., Niu, C. F., et al. (2008). Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCepsilon signaling axis in pulmonary artery smooth muscle cells. Free Radical Biology & Medicine, 45, 1223–1231.
Wang, Q. S., Zheng, Y. M., Dong, L., Ho, Y. S., Guo, Z., & Wang, Y. X. (2007). Role of mitochondrial reactive oxygen species in hypoxia-dependent increase in intracellular calcium in pulmonary artery myocytes. Free Radical Biology & Medicine, 42, 642–653.
Brennan, L. A., Steinhorn, R. H., Wedgwood, S., et al. (2003). Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: A role for NADPH oxidase. Circulation Research, 92, 683–691.
Killilea, D. W., Hester, R., Balczon, R., Babal, P., & Gillespie, M. N. (2000). Free radical production in hypoxic pulmonary artery smooth muscle cells. American Journal of Physiology. Lung Cellular and Molecular Physiology, 279, L408–L412.
Liu, J. Q., Sham, J. S., Shimoda, L. A., Kuppusamy, P., & Sylvester, J. T. (2003). Hypoxic constriction and reactive oxygen species in porcine distal pulmonary arteries. American Journal of Physiology. Lung Cellular and Molecular Physiology, 285, L322–L333.
Marshall, C., Mamary, A. J., Verhoeven, A. J., & Marshall, B. E. (1996). Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. American Journal of Respiratory Cell and Molecular Biology, 15, 633–644.
Rathore, R., Zheng, Y. M., Li, X. Q., et al. (2006). Mitochondrial ROS-PKCepsilon signaling axis is uniquely involved in hypoxic increase in [Ca2+]i in pulmonary artery smooth muscle cells. Biochemical and Biophysical Research Communications, 351, 784–790.
Waypa, G. B., Guzy, R., Mungai, P. T., et al. (2006). Increases in mitochondrial reactive oxygen species trigger hypoxia-induced calcium responses in pulmonary artery smooth muscle cells. Circulation Research, 99, 970–978.
Weissmann, N., Zeller, S., Schafer, R. U., et al. (2006). Impact of mitochondria and NADPH oxidases on acute and sustained hypoxic pulmonary vasoconstriction. American Journal of Respiratory Cell and Molecular Biology, 34, 505–513.
Bradford, J. R., & Dean, H. P. (1894). The pulmonary circulation. The Journal of Physiology, 16, 34–158.25.
Chen, Q., Vazquez, E. J., Moghaddas, S., Hoppel, C. L., & Lesnefsky, E. J. (2003). Production of reactive oxygen species by mitochondria: Central role of complex III. The Journal of Biological Chemistry, 278, 36027–36031.
Korde, A. S., Yadav, V. R., Zheng, Y. M., & Wang, Y. X. (2011). Primary role of mitochondrial Rieske iron-sulfur protein in hypoxic ROS production in pulmonary artery myocytes. Free Radical Biology & Medicine, 50, 945–952.
Harnisch, U., Weiss, H., & Sebald, W. (1985). The primary structure of the iron-sulfur subunit of ubiquinol-cytochrome c reductase from Neurospora, determined by cDNA and gene sequencing. European Journal of Biochemistry, 149, 95–99.
Zalk, R., Lehnart, S. E., & Marks, A. R. (2007). Modulation of the ryanodine receptor and intracellular calcium. Annual Review of Biochemistry, 76, 367–385.
Zheng, Y. M., Wang, Q. S., Rathore, R., et al. (2005). Type-3 ryanodine receptors mediate hypoxia-, but not neurotransmitter-induced calcium release and contraction in pulmonary artery smooth muscle cells. The Journal of General Physiology, 125, 427–440.
Liao, B., Zheng, Y. M., Yadav, V. R., Korde, A. S., & Wang, Y. X. (2011). Hypoxia induces intracellular Ca2+ release by causing reactive oxygen species-mediated dissociation of FK506-binding protein 12.6 from ryanodine receptor 2 in pulmonary artery myocytes. Antioxidants & Redox Signaling, 14, 37–47.
Waypa, G. B., Marks, J. D., Guzy, R. D., et al. (2013). Superoxide generated at mitochondrial complex III triggers acute responses to hypoxia in the pulmonary circulation. American Journal of Respiratory and Critical Care Medicine, 187, 424–432.
Yadav, V. R., Song, T., Joseph, L., Mei, L., Zheng, Y. M., & Wang, Y. X. (2013). Important role of PLC-gamma1 in hypoxic increase in intracellular calcium in pulmonary arterial smooth muscle cells. American Journal of Physiology. Lung Cellular and Molecular Physiology, 304, L143–L151.
Bansaghi, S., Golenar, T., Madesh, M., et al. (2014). Isoform- and species-specific control of inositol 1,4,5-trisphosphate (IP3) receptors by reactive oxygen species. The Journal of Biological Chemistry, 289, 8170–8181.
Nilius, B., Owsianik, G., Voets, T., & Peters, J. A. (2007). Transient receptor potential cation channels in disease. Physiological Reviews, 87, 165–217.
Lu, W., Wang, J., Shimoda, L. A., & Sylvester, J. T. (2008). Differences in STIM1 and TRPC expression in proximal and distal pulmonary arterial smooth muscle are associated with differences in Ca2+ responses to hypoxia. American Journal of Physiology. Lung Cellular and Molecular Physiology, 295, L104–L113.
Weissmann, N., Sydykov, A., Kalwa, H., et al. (2012). Activation of TRPC6 channels is essential for lung ischaemia-reperfusion induced oedema in mice. Nature Communications, 3, 649.
Goldenberg, N. M., Wang, L., Ranke, H., Liedtke, W., Tabuchi, A., & Kuebler, W. M. (2015). TRPV4 is required for hypoxic pulmonary vasoconstriction. Anesthesiology, 122, 1338–1348.
Hawkins, B. J., Irrinki, K. M., Mallilankaraman, K., et al. (2010). S-glutathionylation activates STIM1 and alters mitochondrial homeostasis. The Journal of Cell Biology, 190, 391–405.
Jiang, Q., Fu, X., Tian, L., et al. (2014). NOX4 mediates BMP4-induced upregulation of TRPC1 and 6 protein expressions in distal pulmonary arterial smooth muscle cells. PloS One, 9, e107135.
Wang, Y. X., & Zheng, Y. M. (2010). ROS-dependent signaling mechanisms for hypoxic Ca2+ responses in pulmonary artery myocytes. Antioxidants & Redox Signaling, 12, 611–623.
Cogolludo, A., Moreno, L., Frazziano, G., et al. (2009). Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction. Cardiovascular Research, 82, 296–302.
Moreno, L., Moral-Sanz, J., Morales-Cano, D., et al. (2014). Ceramide mediates acute oxygen sensing in vascular tissues. Antioxidants & Redox Signaling, 20, 1–14.
Moral-Sanz, J., Gonzalez, T., Menendez, C., et al. (2011). Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries. American Journal of Physiology. Cell Physiology, 301, C186–C194.
Michelakis, E. D., Hampl, V., Nsair, A., et al. (2002). Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circulation Research, 90, 1307–1315.
Weir, E. K., & Archer, S. L. (1995). The mechanism of acute hypoxic pulmonary vasoconstriction: The tale of two channels. The FASEB Journal, 9, 183–189.
Archer, S. L., London, B., Hampl, V., et al. (2001). Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel Kv1.5. The FASEB Journal, 15, 1801–1803.
Archer, S. L., Wu, X. C., Thebaud, B., et al. (2004). Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: Ionic diversity in smooth muscle cells. Circulation Research, 95, 308–318.
Somlyo, A. P., & Somlyo, A. V. (2003). Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiological Reviews, 83, 1325–1358.
Manickam, N., Patel, M., Griendling, K. K., Gorin, Y., & Barnes, J. L. (2014). RhoA/Rho kinase mediates TGF-beta1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species. American Journal of Physiology Renal Physiology, 307, F159–F171.
Jernigan, N. L., Walker, B. R., & Resta, T. C. (2008). Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia. American Journal of Physiology. Lung Cellular and Molecular Physiology, 295, L515–L529.
Dada, L. A., Novoa, E., Lecuona, E., Sun, H., & Sznajder, J. I. (2007). Role of the small GTPase RhoA in the hypoxia-induced decrease of plasma membrane Na,K-ATPase in A549 cells. Journal of Cell Science, 120, 2214–2222.
Santulli, G., Xie, W., Reiken, S. R., & Marks, A. R. (2015). Mitochondrial calcium overload is a key determinant in heart failure. Proceedings of the National Academy of Sciences of the United States of America, 112, 11389–11394.
Montero, M., Alonso, M. T., Carnicero, E., et al. (2000). Chromaffin-cell stimulation triggers fast millimolar mitochondrial Ca2+ transients that modulate secretion. Nature Cell Biology, 2, 57–61.
Drummond, R. M., & Fay, F. S. (1996). Mitochondria contribute to Ca2+ removal in smooth muscle cells. Pflügers Archiv, 431, 473–482.
Marchi, S., & Pinton, P. (2014). The mitochondrial calcium uniporter complex: Molecular components, structure and physiopathological implications. The Journal of Physiology, 592, 829–839.
Hong, Z., Chen, K. H., Dasgupta, A., et al. (2016). miR-138 and miR-25 downregulate MCU, causing pulmonary arterial hypertension's cancer phenotype. American Journal of Respiratory and Critical Care Medicine, 195(4), 515–529.
Patriarca, P., Cramer, R., Moncalvo, S., Rossi, F., & Romeo, D. (1971). Enzymatic basis of metabolic stimulation in leucocytes during phagocytosis: The role of activated NADPH oxidase. Archives of Biochemistry and Biophysics, 145, 255–262.
Mittal, M., Gu, X. Q., Pak, O., et al. (2012). Hypoxia induces Kv channel current inhibition by increased NADPH oxidase-derived reactive oxygen species. Free Radical Biology & Medicine, 52, 1033–1042.
Weissmann, N., Voswinckel, R., Hardebusch, T., et al. (1999). Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction. The American Journal of Physiology, 276, L90–L95.
Shaifta, Y., Snetkov, V. A., Prieto-Lloret, J., et al. (2015). Sphingosylphosphorylcholine potentiates vasoreactivity and voltage-gated Ca2+ entry via NOX1 and reactive oxygen species. Cardiovascular Research, 106, 121–130.
Kroller-Schon, S., Steven, S., Kossmann, S., et al. (2014). Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models. Antioxidants & Redox Signaling, 20, 247–266.
Schulz, E., Wenzel, P., Munzel, T., & Daiber, A. (2014). Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. Antioxidants & Redox Signaling, 20, 308–324.
Mistry, Y., Poolman, T., Williams, B., & Herbert, K. E. (2013). A role for mitochondrial oxidants in stress-induced premature senescence of human vascular smooth muscle cells. Redox Biology, 1, 411–417.
Dikalov, S. I., Nazarewicz, R. R., Bikineyeva, A., et al. (2014). Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension. Antioxidants & Redox Signaling, 20, 281–294.
Daiber, A., Di Lisa, F., Oelze, M., et al. (2017). Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function. British Journal of Pharmacology, 174(12), 1670–1689. doi:10.1111/bph.13403.
Doughan, A. K., Harrison, D. G., & Dikalov, S. I. (2008). Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: Linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circulation Research, 102, 488–496.
Kimura, S., Zhang, G. X., Nishiyama, A., et al. (2005). Mitochondria-derived reactive oxygen species and vascular MAP kinases: Comparison of angiotensin II and diazoxide. Hypertension, 45, 438–444.
Wenzel, P., Mollnau, H., Oelze, M., et al. (2008). First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxidants & Redox Signaling, 10, 1435–1447.
Zibara, K., Zeidan, A., Bjeije, H., Kassem, N., Badran, B., & El-Zein, N. (2017). ROS mediates interferon gamma induced phosphorylation of Src, through the Raf/ERK pathway, in MCF-7 human breast cancer cell line. Journal of Cell Communication and Signaling, 11(1), 57–67.
Acknowledgement
We thank Ms. Sudeshna Sadhu and Mr. Vic Maietta for proofreading of this chapter.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Song, T., Zheng, YM., Wang, YX. (2017). Cross Talk Between Mitochondrial Reactive Oxygen Species and Sarcoplasmic Reticulum Calcium in Pulmonary Arterial Smooth Muscle Cells. In: Wang, YX. (eds) Pulmonary Vasculature Redox Signaling in Health and Disease. Advances in Experimental Medicine and Biology, vol 967. Springer, Cham. https://doi.org/10.1007/978-3-319-63245-2_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-63245-2_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-63244-5
Online ISBN: 978-3-319-63245-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)